[Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010919:Placebos
D014151:Anti-Anxiety Agents; D010919:Placebos; D001569:Benzodiazepines
Valoración clínica comparativa en doble ciego de un nuevo ansiolítico, Zami-905: propazepam.